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Alzheimer’s disease (AD) is a serious neurodegenerative disorder and its cause remains largely elusive. In past years, ge-
nome-wide association (GWA) studies have provided an effective means for AD research. However, the univariate method 
that is commonly used in GWA studies cannot effectively detect the biological mechanisms associated with this disease. In this 
study, we propose a new strategy for the GWA analysis of AD that combines random forests with enrichment analysis. First, 
backward feature selection using random forests was performed on a GWA dataset of AD patients carrying the apolipoprotein 
gene (APOEε4) and 1058 susceptible single nucleotide polymorphisms (SNPs) were detected, including several known 
AD-associated SNPs. Next, the susceptible SNPs were investigated by enrichment analysis and significantly-associated gene 
functional annotations, such as ‘alternative splicing’, ‘glycoprotein’, and ‘neuron development’, were successfully discovered, 
indicating that these biological mechanisms play important roles in the development of AD in APOEε4 carriers. These findings 
may provide insights into the pathogenesis of AD and helpful guidance for further studies. Furthermore, this strategy can easily 
be modified and applied to GWA studies of other complex diseases. 
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Alzheimer’s disease (AD) is a common neurodegenerative 
disease that is characterized by degenerated memory, 
thinking and speaking impairment as well as disorders in 
behavior. Late-onset AD (LOAD) which usually occurs 
after 65 years of age accounts for 90% of AD patients [1]. 
As populations age, it has been estimated that the number of 
people affected by this disease will soar to about 80 million 
by 2040; this number includes 60 million people living in 
the developing countries, including China [2]. AD is already 
becoming a critical social and medical issue and further 
research into this debilitating disease is urgently required. 
Although the pathogenesis of AD has not been elucidated 
completely, previous researches have demonstrated that 
genetic factors play a major role [3]. Recently, APOE 
(apolipoprotein E), NGFR (nerve growth factor receptor), 
and presenilin-1/presenilin-2 have been implicated in AD 
[4–8]. APOEε4 has been verified as a genetic risk factor for 
AD [6–8], and the abnormal expression of APOEε4 has 
been reported to lead to impairment of the cholinergic neu-
ron and the abnormal increase of amyloidβ protein, which in 
turn triggers the formation of neurofibrillary tangles and 
disruption of the neuronal cytoskeleton [7]. Almost two- 
thirds of AD patients are APOEε4 carriers and the risk has 
been found to increase significantly with the number of 
APOE ε4 copies [8]. The associated mechanism is reported 
to be very complicated; for example, there are multiple sus-
ceptible genes, such as GAB2, that contribute to AD coop-
eratively with APOEε4 [9,10]. 
With the rapid development of high-throughput geno-
typing chips, genome-wide association (GWA) studies have  
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been widely employed in many researches on a variety of 
complex genetic diseases [9,11–18]. Under the “common 
disease, common variant” hypothesis, GWA studies have 
been used to screen thousands or millions of single nucleo-
tide polymorphisms (SNPs) by comparing case and control 
subjects to detect disease-associated alleles [19]. Many 
GWA studies on AD [9,16,17] have been carried out in re-
cent years and Reiman et al [9], for example, identified six 
susceptible SNPs in the GAB2 gene that were associated 
with AD. 
Univariate methods, such as the chi-square test [9], the 
trend test [18] and the likelihood ratio test [20], are most 
commonly used in GWA studies. However, these tests as-
sume mutual independency between features and, therefore, 
possible feature interactions are ignored [15,21]. Conse-
quently, when applied to GAW studies, they may fail to 
detect SNPs that are associated with a disease via genetic 
interactions. Furthermore, it is unfeasible to use these 
methods to evaluate the statistical significance of some of 
the high-level biological mechanisms that have been impli-
cated in complex diseases and which may better elucidate 
the pathogenesis of the disease. To address this problem, we 
proposed a novel strategy that combines random forests and 
enrichment analysis to analyze the GWA data. Our strategy 
is based on the following two premises: (i) random forests 
can delineate interactions between SNPs, and therefore can 
select disease-associated SNPs more effectively [15,21]; 
and (ii) enrichment analysis of the selected SNPs can detect 
significant functional annotations and corresponding mo-
lecular biology mechanisms [22,23]. We applied this strat-
egy to a GWA dataset and discovered several biological 
mechanisms in APOEε4 carriers that were significantly as-
sociated with AD. The findings from this study may help 
further elucidate the pathogenesis of AD. 
1  Materials and methods 
1.1  Dataset 
The GWA data of 644 APOEε4 carriers (117 cases and 527 
controls, all over the age of 65) from a previous study on 
LOAD [9] was used in this work. After removing unquali-
fied SNPs as described previously [9] (such as minor allele 
frequencies<2%, or Hardy Weinberg equilibrium P-value 
<0.01), the GWA data included 312316 SNPs from the total 
of 502267 SNPs that were genotyped by SNP-arrays. 
1.2  Random forests 
Random forest is a powerful statistical machine learning 
method that combines many independent decision      
trees [24,25]. To build a single decision tree, two stochastic 
processes are adopted. Firstly, bagging is used to construct a 
training subset by randomly sampling from the original data. 
Secondly, at each node of a decision tree, a subset of varia- 
bles numbering m is selected randomly from all the p varia-
bles without replacement, and the optimal split based on this 
subset is used to split the node. These two random processes 
effectively reduce the correlation between independent trees, 
thereby improving the robustness of random forests and 
avoiding an over-fitting problem. Next, for tree t, the corre-
sponding out-of-bag data is used as the test data for evalu-
ating misclassification error. One commonly adopted for-
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where N is the number of trees in the random forests, 
countt,ini is the number of correctly classified samples and 
countt,v is the number of correctly classified samples by tree 
t in a new test data in which v is randomly permuted. The 
importance parameter reflects the contribution of a feature 
variable to data classification. In addition, the hierarchical 
topology of decision trees is advantageous in handling 
complicated interactions between features; therefore, ran-
dom forests have recently been used successfully in GWA 
studies [12–15]. 
In this study, we constructed random forests using Wil-
lows software [26] and performed backward feature selec-
tion to find susceptible SNPs in AD patients carrying AP-
OEε4. We built the random forests using all available SNPs 
(denoted by S0), and kept only the SNPs with positive  
importance (denoted by S1). This procedure was repeated 
until all the remaining SNPs had positive importance. This 
optimal subset of SNPs was then used for enrichment anal-
ysis. 
1.3  Enrichment analysis 
By taking advantage of various bioinformatics databases 
and analysis tools, enrichment analysis aims to detect the 
correlation between a cohort of gene sets and a reference 
gene set that shares the same or similar functions and con-
sequently discovers statistically significant biological 
mechanisms [22,23,27–31]. Statistical methods such as the 
Fisher test [22,23,30] and the chi-square test [31], are usu-
ally adopted in enrichment analysis. The DAVID software 
[22,23] that consists of integrated online databases and ana-
lytic tools, was employed in this study. For example, the 
“Gene Name Batch Viewer” can quickly map a list of SNPs 
to the corresponding genes. DAVID uses EASE scores [32] 
based on a modified Fisher test to measure the association 
between functional annotation and genes. The software also 
provides different approaches for detailed enrichment anal-
ysis, including a gene annotation chart and functional anno-
tation clustering, which assisted our research on the 
AD-associated biological mechanisms in APOEε4 carriers. 
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2  Results and discussion 
2.1  SNP screening based on random forests 
Before selecting the AD-associated SNPs in APOEε4 carri-
ers using random forests, the number of trees (N) and the 
number of variables (m) were determined based on the 
characteristics of the GWA data. The dimensionality of the 
data used in GWA studies is very high and the number of 
SNPs largely exceeds the sample size n. This phenomenon 
is known as the ‘large p and small n’ problem. A previous 
study [33] had shown that in such a situation, the m and N 
parameters should be large enough during the procedure of 
building random forests. Therefore, taking this requirement 
and computational efficiency into consideration, we set m 
equal to the square root (p) and N to greater than 2p in this 
study. Figure 1A illustrates the relationship of the number 
of selected SNPs and the number of times that feature selec-
tion was performed. Two stages were observed during this 
procedure. The first stage appeared at the beginning of fea-
ture selection, in which a large number of irrelevant SNPs 
were removed quickly. At the end of the first stage, the 
speed of feature selection decreased gradually. The subse-
quent second stage had a similar trend as the first except 
that feature selection became even slower at the end of this 
stage. Finally, 1058 AD-associated candidate SNPs were 
selected. A retrospection analysis of the overall change of 
the importance of these SNPs showed an obvious increasing 
trend of importance as feature selection was performed 
(Figure 1B). Specifically, in the first stage of feature selec-
tion, the overall importance increased slowly probably be-
cause of the existence of a large number of irrelevant fea-
tures in the early stage of the process. However, after most 
of the disease-unrelated SNPs were removed, the sig-
nal-to-noise ratio of the data improved significantly in the 
second stage and the importance of the SNPs correspond-
ingly increased. Finally it should be pointed out that the 
small local fluctuations on the curve in Figure 1B are prob-
ably caused by the randomness in the procedure that was 
used to construct the training/test data and decision trees. 
To verify the results obtained by random forests, we an-
alyzed the selected SNPs and their corresponding im-
portance. Firstly, we calculated the P-values of all the SNPs 
using the chi-square test under the assumption that there 
was no association between these SNPs and AD, and com-
pared the values with the importance of the corresponding 
SNPs (Figure 2). For a better illustration, we used local re-
gression (loess) to generate the fitting curve. Figure 2 shows 
that there was an overall declining trend of importance with 
increases in the P-values. In addition, in the right part of the 
fitting curve, the SNPs’ importance decreased significantly 
with increasing P-values while, in the left part of the fitting 
curve, this trend was not apparent. One major reason for this 
difference is that these SNPs cooperate together to affect the 
pathogenesis of the disease and therefore, using a univariate 
method, it is difficult to associate them with AD. 
Next, we examined the distribution of the selected SNPs 
on the human genome and the results are shown in Figure 
3A. We found that 96 of the SNPs were located on chro-
mosome 11 which was significantly higher than the number 
of SNPs on the other chromosomes. An in-depth analysis of 
the SNP locations on chromosome 11 (Figure 3B) identified 
several SNPs with high importance at position 11q14.1, 
indicating this region of the chromosome may harbor sus-
ceptible genes in APOEε4 carriers. A literature search  
revealed that the GAB2 gene, which is located in this   
region, has a significant influence on the prevalence of        
AD [9,34,35]. In these earlier studies it was shown that 
GAB2 is associated with the phosphorylation of the tau 
protein and the formation of neurofibrillary tangles that play 
an important role in AD development. We analyzed all the  
 
 
Figure 1  The feature selection procedure based on random forests for AD-associated SNPs. A, The number of SNPs in each feature selection run. B, The  
overall importance of the 1058 selected SNPs. 
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GAB2-related SNPs in our candidate SNP list and discov-
ered that many of the SNPs were known to be associated 
with AD (Table 1). In addition, we found some AD-associ- 
ated candidate genes, including APOC1 [36] and NGFR [4], 
in the same region of chromosome 11. APOC1 together 
with APOE has been demonstrated to influence the devel-
opment of AD [36]. A SNP (rs4420638) in the APOC1 gene 
has also been verified to be significantly associated with 
AD [37]. 
2.2  Analysis of AD-associated biological mechanisms 
We performed an enrichment analysis of the 1058 AD-  
associated candidate SNPs identified by random forests. Us-
ing the analytic tools provided in DAVID, 749 SNPs were 
mapped to 520 genetic functional annotations from various 
bioinformatics databases, such as Uniprot, PIR, GO, and 
InterPro; 144 of the annotations had P-value less than 0.01. 
To address the issue of multiple comparisons, the Benjamini 
correction was adopted and a threshold of 0.01 for the cor-
rected P-values was used to determine statistical signifi-
cance. Finally, 27 functional annotations were identified to 
be significantly associated with AD in APOEε4 carriers 
(Table 2).  
The most significant functional annotation was “alterna-
tive splicing” with a corrected P-value of 1.13×108, indi- 
 
 
Figure 2  Comparison of the importance of the SNPs with the P-value calculated using the chi-square test (the fitted curve of importance against P-value  
was obtained by local regression). 
 
Figure 3  Distribution of the AD-associated SNPs on the human chromosomes. A, The distribution of the AD-associated candidate SNPs in APOEε4 carri- 
ers. B, The importance of AD-associated SNPs on chromosome 11 in APOEε4 carriers. 
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Table 1  Known susceptible SNPs in the GAB2 gene that are among the selected candidate SNPs 
SNP_ID Chromosome Allele Position 
rs1385600 11 C/T 77613814 
rs4945261 11 A/G 77667908 
rs7101429 11 A/G 77670615 
rs10793294 11 A/C 77674051 
rs7115850 11 C/G 77722719 
rs2373115 11 G/T 77768798 
Table 2  Functional annotations of the AD-associated SNPs in APOEε4 carriers 
Category Functional annotation P-value Benjamini P-value 
SP_PIR_KEYWORDS Alternative splicing 2.40×1011 1.13×108 
UP_SEQ_FEATURE Splice variant 7.33×1011 1.69×107 
SP_PIR_KEYWORDS Glycoprotein 1.83×108 4.31×106 
GOTERM_BP_FAT Neuron development 1.04×108 6.66×106 
GOTERM_BP_FAT Neuron projection morphogenesis 1.39×108 7.17×106 
GOTERM_BP_FAT Cell morphogenesis involved in neuron differentiation 8.92×109 7.64×106 
GOTERM_BP_FAT Neuron projection development 6.97×109 8.96×106 
GOTERM_BP_FAT Cell morphogenesis involved in differentiation 2.64×108 1.13×105 
GOTERM_BP_FAT Neuron differentiation 3.18×108 1.17×105 
GOTERM_BP_FAT Axonogenesis 5.49×109 1.41×105 
UP_SEQ_FEATURE Glycosylation site: N-linked (GlcNAc...) 1.41×108 1.62×105 
GOTERM_BP_FAT Axon guidance 1.68×107 5.41×105 
GOTERM_BP_FAT Cell projection morphogenesis 3.34×107 9.54×105 
INTERPRO IPR013098: Immunoglobulin I-set 1.80×107 2.15×104 
GOTERM_BP_FAT Cell part morphogenesis 8.58×107 2.21×104 
GOTERM_BP_FAT Cell motion 2.13×106 4.56×104 
GOTERM_BP_FAT Cell projection organization 2.08×106 4.86×104 
GOTERM_BP_FAT Cell morphogenesis 6.47×106 1.28×103 
UP_SEQ_FEATURE Domain: Fibronectin type-III 1 3.21×106 2.47×103 
UP_SEQ_FEATURE Topological domain:Cytoplasmic 5.37×106 2.47×103 
UP_SEQ_FEATURE Domain: Ig-like C2-type 3 4.53×106 2.61×103 
GOTERM_BP_FAT Biological adhesion 1.75×105 3.00×103 
GOTERM_BP_FAT Cell adhesion 1.73×105 3.18×103 
UP_SEQ_FEATURE Domain: Fibronectin type-III 2 1.12×105 4.30×103 
INTERPRO IPR008957: Fibronectin, type III-like fold 7.33×106 4.38×103 
GOTERM_BP_FAT Cell-cell adhesion 3.08×105 4.93×103 
GOTERM_BP_FAT Cellular component morphogenesis 6.49×105 9.77×103 
 
cating a strong association between alternative splicing and 
AD in the APOEε4 carriers. Alternative splicing is an im-
portant gene regulation mechanism, which promotes com-
plexity of gene expression and diversity of proteins in eu-
karyotes [38]. Studies have shown that there is an intrinsic 
relationship between alternative splicing and the pathogene-
sis of AD [39,40]. For example, Tollervey et al. [39] inves-
tigated alternative splicing in patients with AD and other 
neurodegenerative diseases and identified two kinds of al-
ternative splicing: one was age-related splicing changes in 
normal individuals and the other was disease-specific splic-
ing changes that played an important role in regulating the 
genes involved in metabolism and DNA repairing in AD 
patients. Another significant functional annotation was 
“glycoprotein” which refers to proteins with oligosaccharide 
chains that are covalently attached to the polypeptide side 
chains. Glycoproteins usually participate in various physio-
logical functions such as material transportation, nerve 
conduction, cell development and differentiation. It has 
been reported that excessive glycosylation of the tau protein 
triggers the instability of microtubules leading to serious 
degeneration or even disability of the neurofibrils which 
contributes to the emergence and development of AD [41]. 
Other significant AD-associated annotations have been re-
ported in APOEε4 carriers [42,43], including “cell mor-
phogenesis involved in neuron differentiation” and “neuron 
development”. For comparison, we generated a list of sig-
nificant SNPs detected by the univariate method; however, 
enrichment analysis failed to give any significantly associ-
ated functional annotations. One possible explanation for 
this result is that the univariate method does not take into 
account the synergy of multiple risk-factors and some 
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AD-associated SNPs that affect the disease indirectly were 
neglected, leading to the low abundance of functional anno-
tations. 
From the results of the enrichment analysis, we noticed 
that some seemingly different annotations actually repre-
sented similar or even the same functions. For example, the 
functional annotations “cell morphogenesis involved in 
neuron differentiation” and “cell morphogenesis involved in 
differentiation” have different names and P-values (Table 2), 
but both terms describe cell morphogenesis in differentia-
tion. In the GO database the former term is a child node of 
the latter with the “is a” relationship, indicating that “cell 
morphogenesis involved in neuron differentiation” is a sub-
type of “cell morphogenesis involved in differentiation”. To 
avoid redundant analysis and to better understand the rela-
tions between the biology mechanisms, we performed func-
tional annotation clustering using DAVID. The most signif-
icant cluster included 13 different functional annotation 
terms and the frequency of occurrence of each of these 
terms in the cluster is shown in Figure 4. The term “axon 
guidance” was the least observed with an occurrence fre-
quency of 0.27; the other annotations had an occurrence 
frequency more than 0.40 with “neuron differentiation” be-
ing the most frequently observed (0.65). 
Because all the annotations in this cluster were from the 
GO database, we further investigated the semantic relation-
ships between them. We listed all the GO annotations relat-
ed to the “axon guidance” annotation (GO relationships are 
represented as either “is a” or “part of”) and found that all 
the other annotations in the cluster were in fact parent nodes 
of “axon guidance”, as illustrated in Figure 5. Specifically, 
the “axonogenesis” term was the only direct parent node 
and all the other annotation terms were indirect parent 
nodes. Interestingly, the parent nodes themselves were also  
highly related (Figure 5), indicating that the topology of the 
semantic relationships was consistent with the results of the 
functional annotation clustering. Finally, we performed a 
topological analysis by combing the P-values from the en-
richment analysis, and found that the most significant anno-
tation “neuron development” appeared in the middle of the 
map. More interestingly, we observed that the statistical 
significance of the annotations tended to decrease as the 
distance to “neuron development” in the map became longer. 
For example, with their increasing distance to “neuron de-
velopment”, the P-values of “cell morphogenesis involved 
in neuron differentiation” (7.6×106), “axonogenesis” (1.4× 
105) and “axon guidance” (5.4×105) increased and became 
less significant. These findings suggest that neuron devel-
opment is the most significant AD-associated biological 
mechanism in the APOEε4 carriers. 
3  Conclusion 
In this work, we introduced a new approach for the GWA 
study of AD in APOEε4 carriers. To detect disease-associ- 
ated functional annotations and corresponding biological 
mechanisms, we proposed a data analysis strategy that 
combines random forests with enrichment analysis and 
found that significant AD-associated biological mechanisms, 
such as alternative splicing, glycoprotein, and neuron de-
velopment, were successfully identified using this novel 
approach. These mechanisms have been reported previously 
in other studies, confirming the effectiveness of our method. 
Further studies on these biological mechanisms will help to 
better understand the pathogenesis of AD and provide 
guidance for clinical treatment plans.
 
 
Figure 4  Distribution of functional annotation terms in the most significant cluster. 
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Figure 5  Topology map of the GO annotation terms in the most significant cluster. 
The strategy of combining random forests and enrich-
ment analysis takes into account the effect of SNP interac-
tions, and can detect disease-associated SNPs and the cor-
responding biological mechanisms more sensitively. There-
fore, this strategy addresses some of the drawbacks of the 
current analytical methods that are used in GWA studies. 
Thus, using random forests to generate candidate SNPs is an 
efficient alternative to the common enrichment analysis 
approaches. Furthermore, the proposed method can be easi-
ly generalized and applied to GWA studies of other com-
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plex diseases. However, it should be noted that compared 
with the traditional univariate methods, the importance of 
the features from random forests cannot be used to directly 
reflect the statistical significance of the detected SNPs. Be-
cause both random forests and enrichment analysis are ex-
ploratory methods, further biological experiments are re-
quired to confirm the findings reported in this study. 
This work was supported by the National Natural Science Foundation of 
China (Nos. 2100230024 and 2100230023). 
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